1. Differential cytotoxic effects of docetaxel in a range of mammalian tumor cell lines and certain drug resistant sublinesin vitro

   • Bridget T. Hill
   • Richard D. H. Whelan
   • Louise K. Hosking

   Preclinical Studies Pages: 169 - 182

2. In vitro comparison of cytotoxic effects of crotoxin against three human tumors and a normal human epidermal keratinocyte cell line

   • Colette J. Rudd
   • Luis J. Viskatis
   • Martin A. Etcheverry

   Brief Report Pages: 183 - 184

3. Reversal of multidrug resistance in murine fibrosarcoma cells by thioxanthene flupentixol

   • Dominic Fan
   • George Poste
   • Isaiah J. Fidler

   Preclinical Studies Pages: 185 - 195

4. Intraperitoneal 5-fluoro-2′-deoxyuridine with escalating doses of leucovorin: Pharmacology and clinical tolerance

   • Franco M. Muggia
   • Anil Tulpule
   • Kenneth K. Chan

   Phase I Studies Pages: 197 - 206

5. Pyrazine diazohydroxide (NSC-361456)

   • Madhav V. Dhodapkar
   • Ronald L. Richardson
   • Matthew M. Ames

   Phase I Studies Pages: 207 - 216

6. A phase II trial of oral etoposide with mitoxantrone and ifosfamide/mesna consolidated with intravenous etoposide, methylprednisolone, high-dose arabinoside, and cisplatin as salvage therapy for relapsing and/or refractory lymphomas

   • Jorge E. Romaguera
   • M. Alma Rodriguez
   • Fernando Cabanillas

   Phase II Studies Pages: 217 - 222

7. Phase I/II study of cisplatin, 5-fluorouracil and α-interferon for recurrent carcinoma of the head and neck

   • Martin H. Huber
   • Mihran Shirinian
   • Waun Ki Hong

   Phase II Studies Pages: 223 - 229

8. Vinorelbine in pre-treated advanced head & neck squamous cell carcinoma

   • Alessandro Testolin
   • Gianfranco Recher
   • Giampietro Gasparini

   Brief Report Pages: 231 - 234

9. Phase II study of deoxyspergualin in metastatic breast cancer

   • Kapil Dhingra
   • Vicente Valero
   • Gabriel Hortobagyi

   Phase II Studies Pages: 235 - 241

10. Phase II clinical trial of didemnin B in previously treated small cell lung cancer

    • Dong M. Shin
    • Paul Y. Holoye
    • Waun Ki Hong

    Phase II Studies Pages: 243 - 249

11. Phase II trial of fotemustine in patients with metastatic malignant melanoma

    • Carla I. Falkson
    • Geoffrey Falkson
    • Hendré C. Falkson

    Phase II Studies Pages: 251 - 254

12. Trimetrexate in advanced hormone-refractory prostate cancer

    • Robert S. Witte
    • Beow Yong Yeap
    • Donald L. Trump

    Phase II Studies Pages: 255 - 258

13. A Southwest Oncology Group phase II evaluation of fluderabine monophosphate in sarcoma

    • Micheal R. Grever
    • Jacqueline Benedetti
    • Shaker R. Dakhil

    Brief Report Pages: 259 - 261

14. Phase II trial of piroxantrone in metastatic gastric adenocarcinoma

    • Richard Pazdur
    • Beth Bready
    • Rodger J. Winn

    Brief Report Pages: 263 - 265

15. Phase II study of amonafide in gastric adenocarcinoma

    • Michael R. Mullane
    • Richard L. Schilsky
    • Al. B. Benson III

    Phase II Studies Pages: 267 - 270